Osteoporosis Clinical Trial
Official title:
Menier's Disease - Bone Density Study
Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2028 |
Est. primary completion date | June 30, 2028 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Definite Meniere's disease Exclusion Criteria: - hyperthyroidism - hyperparathyroidism - acromegaly - hypogonadism - diabetes melitus - chronic renal failure - alcoholism - cushing syndrome - rheumatoid arthritis - systemic lupus erythematosus - ankylosing spondylitis - inflammatory bowel disease - obstructive lung disease - sarcoidosis - amyloidosis - celiac disease. - chronic treatment with bisphosphonates - chronic treatment with glucocorticoids - chronic treatment with androgen deprivation therapy - chronic treatment with gonadotropin releasing hormone agonist chronic treatment with aromatase inhibitor chronic treatment with loop diuretics chronic treatment with proton pump inhibitors chronic treatment with anti-seizure drugs chronic treatment with warfarin chronic treatment with SSRI chronic treatment with alpha or beta-blockers |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
HaEmek Medical Center, Israel |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vitamin D plasma levels | Vitamin D plasma levels | baseline | |
Primary | Vitamin D plasma levels | Vitamin D plasma levels | one year follow up | |
Primary | Vitamin D plasma levels | Vitamin D plasma levels | two years follow-up | |
Primary | Z-score and T-score of femur and lumbur spine | DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score | baseline | |
Primary | Z-score and T-score of femur and lumbur spine | DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score | one year follow up | |
Primary | Z-score and T-score of femur and lumbur spine | DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score | two years follow-up | |
Secondary | positive ortostatic hypotension | drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive | baseline | |
Secondary | positive ortostatic hypotension | drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive | one year follow up | |
Secondary | positive ortostatic hypotension | drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive | Two years follow-up | |
Secondary | cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete | a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function | baseline | |
Secondary | cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete | a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function | one year follow up | |
Secondary | cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete | a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function | two years follow-up | |
Secondary | ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test | cervical vestibular evoked myogenic potential exam | baseline | |
Secondary | ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test | cervical vestibular evoked myogenic potential exam | one year follow up | |
Secondary | ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test | cervical vestibular evoked myogenic potential exam | two years follow-up | |
Secondary | Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam | audiology exam | baseline | |
Secondary | Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam | audiology exam | one year follow up | |
Secondary | Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam | audiology exam | two years follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A | |
Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A |